Westport Resources Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Westport Resources Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-150	Closed	-$21K	–	785
2015 Q4	$21K	Buy	+150	New	+$20.8K	0.01%	599
2015 Q2	–	Sell	-500	Closed	-$86K	–	963
2015 Q1	$86K	Sell	500 -790	-61%	-$136K	0.02%	431
2014 Q4	$211K	Sell	1,290 -150	-10%	-$24.9K	0.06%	294
2014 Q3	$231K	Sell	1,440 -670	-32%	-$103K	0.06%	273
2014 Q2	$310K	Sell	2,110 -516	-20%	-$71.6K	0.08%	239
2014 Q1	$364K	Buy	2,626 +1,005	+62%	+$151K	0.1%	218
2013 Q4	$205K	Buy	+1,621	New	+$168K	0.06%	282

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westport Resources Management's JAZZ Position: Q1 2016 in Review

Westport Resources Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2016, closing a stake of 150 shares — an estimated $21K sold.

Westport Resources Management first reported a position in JAZZ in Q4 2013 and held it in 7 quarters. The position peaked at $364K in Q1 2014. 339 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

Westport Resources Management reported no remaining Jazz Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Westport Resources Management sold 150 Jazz Pharmaceuticals shares in Q1 2016, an estimated $21K.
Westport Resources Management first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 7 quarters.
Westport Resources Management's Jazz Pharmaceuticals position peaked at $364K in Q1 2014.
339 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on Westport Resources Management's 13F filing for Q1 2016, filed 16 May 2016.